XOOMAR

CytoMed Therapeutics Ltd (GDTC)

Every FINRA and SEC series the site collects for CytoMed Therapeutics Ltd: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq.

Download CSV

4K

Short interest

settlement 2026-08-14

1.0

Days to cover

-25.6% vs prior

82.1%

Short share of volume

2026-09-11

13,432

Fails to deliver

settlement 2026-07-27

$300K

Insider flow, 90 days

2 buys, 0 sells

As of 2026-09-11.

Short interest

FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSON

As of 14 August 2026, short interest in GDTC is 4,207 shares, down 25,850 shares over the last month. Over the last 48 readings it ranged from 4,207 shares (14 August 2026) to 225,911 shares (15 January 2025). The latest reading sits at the bottom of that range. At the reported average volume of 30K shares a day that is 1.0 days to cover.

Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/gdtc" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-08-144,207-25.6%30,0241.00
2026-07-315,655-81.2%329,1451.00
2026-07-1530,057-20.7%9,9183.03
2026-06-3037,906-17.6%12,8502.95
2026-06-1546,008-32.3%23,1371.99
2026-05-2967,963-4.4%29,9862.27
2026-05-1571,090+4.3%26,4692.69
2026-04-3068,135-5.3%6,07211.22
2026-04-1571,945-13.0%6,93810.37
2026-03-3182,681-29.4%8,2849.98
2026-03-13117,191-14.6%12,1189.67
2026-02-27137,172-30.6%32,5924.21
2026-02-13197,539+1284.3%3,303,6001.00
2026-01-3014,270-46.7%28,5941.00
2026-01-1526,790+27.3%45,2181.00
2025-12-3121,050-49.1%28,4331.00
2025-12-1541,345+50.4%52,1541.00
2025-11-2827,483+24.5%107,8551.00
2025-11-1422,080+31.3%167,3451.00
2025-10-3116,818-83.8%181,4921.00
2025-10-15103,710+264.4%177,6421.00
2025-09-3028,459-33.6%14,0982.02
2025-09-1542,851+27.8%13,9993.06
2025-08-2933,520-11.8%12,4522.69

Daily short volume

FINRA Reg SHO, last 60 sessions. JSON

As of 11 September 2026, the short share of GDTC volume is 82.1%, down 12.1 points over the last five sessions. Over the last 52 readings it ranged from 0.3% (1 July 2026) to 98.4% (9 July 2026). The latest reading is 40.4 points above the 30-session average of 41.7%, on 8K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-09-116K8K82.1%0
2026-09-105905K11.8%0
2026-09-094K15K26.3%0
2026-09-083022K14.7%0
2026-09-042K6K29.9%0
2026-09-03828794.3%0
2026-09-022K4K47.3%0
2026-09-01484998.0%37
2026-08-312769K3.1%100
2026-08-284061K29.1%0
2026-08-272K7K21.9%0
2026-08-268123K32.2%0
2026-08-256K17K38.1%0
2026-08-2424K59K40.6%0
2026-08-2118K22K82.4%0
2026-08-201K2K73.0%0
2026-08-195K10K46.4%0
2026-08-182K3K84.2%0
2026-08-174K14K26.5%0
2026-08-1413K14K86.9%0
2026-08-138212167.8%0
2026-08-123K6K55.5%0
2026-08-116444514.4%0
2026-08-109K36K25.6%600
2026-08-07246193.9%0
2026-08-0620K68K29.0%105
2026-08-0511K23K47.5%1,001
2026-08-045117K6.8%0
2026-07-3112816K0.8%0
2026-07-308373K30.2%0

Fails to deliver

SEC, by settlement date. JSON

As of 27 July 2026, the fails-to-deliver balance in GDTC is 13,432 shares, up 12,524 shares over the last settlement date. Over the last 52 readings it ranged from 3 shares (15 April 2026) to 459,147 shares (5 February 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-07-2713,432$0.99$13K
2026-07-17908$0.99$899
2026-07-16828$0.96$795
2026-07-15966$1.03$995
2026-07-102,129$1.02$2K
2026-07-09415$0.96$398
2026-07-08718$0.95$682
2026-07-07545$0.97$529
2026-06-181,373$1.09$1K
2026-06-11165$1.11$183
2026-06-10552$1.10$607
2026-06-09854$1.08$922
2026-04-2428$1.01$28
2026-04-21864$0.98$847
2026-04-153$0.99$3
2026-04-141,472$0.94$1K
2026-04-09328$0.98$321
2026-04-02275$1.04$286
2026-03-032,867$1.06$3K
2026-02-274,153$1.08$4K
2026-02-201,874$1.03$2K
2026-02-178,897$1.01$9K
2026-02-13696$0.95$661
2026-02-117,302$1.07$8K
2026-02-1014,565$1.08$16K
2026-02-09119,732$1.19$142K
2026-02-06324,251$1.08$350K
2026-02-05459,147$0.83$381K
2026-01-27613$0.89$546
2026-01-23183$0.95$174

Insider trades

SEC Form 4, newest first. JSON

Insiders at GDTC reported 2 open-market buys worth $300K in the last 90 days and no open-market sells. Clustered voluntary buying is historically the stronger insider signal because insiders buy for one reason. Latest filing: Choo Chee Kong on 2026-07-20.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-07-20Choo Chee Kongn/aBuy100K$1.50$150K630K
2026-07-14Choo Chee Kongn/aBuy100K$1.50$150K530K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.

Planned sales (Form 144)

Newest first. JSON

1 Form 144 notice on file for GDTC worth $103K at the prices reported; 1 in the last 90 days worth $103K. Latest: mDR Ltd filed on 2026-08-11 to sell 117,337 shares ($103K) from 2026-08-11.

FiledSellerSharesMarket valueOf outstandingSale fromBroker
2026-08-11mDR Ltd10% Stockholder117K$103K0.992%2026-08-11Bank of Sinapore

Large holders (13D and 13G)

One row per reporting person, newest filing first. JSON

1 holder above 5% has filed on GDTC, 1 on Schedule 13D (active intent). The largest reported stake is Choo Chee Kong at 24.3% of the class (2,899,746 shares), filed 2026-07-24 for an event on 2026-07-20.

FiledFormHolderSharesOf classEvent
2026-07-2413D/Ano. 3Choo Chee Kongindividual2.9M24.3%2026-07-20

What this page is

CytoMed Therapeutics Ltd in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.

This page follows CytoMed Therapeutics Ltd (GDTC), SEC CIK 1873093, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and method

Short interest
FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-07-27.JSON and CSV
Planned sales
SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-08-11.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-07-24.JSON and CSV
Insider trades
SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-07-20.JSON and CSV
Company record
EDGAR filing index for CIK 1873093Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
30 requests a minute without a key, 120 a minute with a key from a free account.

Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 12 Sep 05:40 UTC.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other company pages

Datasets

Frequently Asked Questions

How much of GDTC is sold short?
4,207 shares were held short at the 2026-08-14 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is GDTC's daily short volume?
On 2026-09-11, 6,164 of the 7,507 GDTC shares reported to FINRA were sold short, 82.1% of the day's reported volume. Short volume is a flow for one day, not a position.
Does GDTC have fails to deliver?
The SEC's latest file shows 13,432 GDTC shares failed to deliver at settlement 2026-07-27. Fails are reported per settlement date and published twice a month with a lag.
Are GDTC insiders buying or selling?
Insiders at GDTC reported 2 open-market buys worth $300K in the last 90 days and no open-market sells. Clustered voluntary buying is historically the stronger insider signal because insiders buy for one reason. Latest filing: Choo Chee Kong on 2026-07-20.
Have GDTC insiders filed to sell?
1 Form 144 notice on file for GDTC worth $103K at the prices reported; 1 in the last 90 days worth $103K. Latest: mDR Ltd filed on 2026-08-11 to sell 117,337 shares ($103K) from 2026-08-11.
Who owns more than 5% of GDTC?
1 holder above 5% has filed on GDTC, 1 on Schedule 13D (active intent). The largest reported stake is Choo Chee Kong at 24.3% of the class (2,899,746 shares), filed 2026-07-24 for an event on 2026-07-20.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.